We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$77.4B
AUM Growth
-$2.68B
Cap. Flow
-$1.24B
Cap. Flow %
-1.6%
Top 10 Hldgs %
12.38%
Holding
4,070
New
663
Increased
931
Reduced
1,797
Closed
653

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$649M
2
NKE icon
Nike
NKE
+$453M
3
TSLA icon
Tesla
TSLA
+$431M
4
AZN icon
AstraZeneca
AZN
+$389M
5
KO icon
Coca-Cola
KO
+$336M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$897M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$578M
3
MRNA icon
Moderna
MRNA
+$438M
4
AAPL icon
Apple
AAPL
+$417M
5
AON icon
Aon
AON
+$386M

Sector Composition

Rank Sector Weight
1 Technology 20.4%
2 Healthcare 20.27%
3 Consumer Staples 11.15%
4 Consumer Discretionary 9.81%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
26
Vodafone
VOD
$36.7B
$442M 0.57%
28,577,732
-1,232,244
-4% -$20.4M
WMT icon
27
Walmart Inc
WMT
$901B
$424M 0.55%
9,121,500
+2,582,700
+39% +$124M
BMY icon
28
Bristol-Myers Squibb
BMY
$130B
$421M 0.54%
7,120,925
-185,000
-3% -$12.2M
AZN icon
29
AstraZeneca
AZN
$246B
$413M 0.53%
3,442,188
+3,341,338
+3,313% +$389M
ICLR icon
30
Icon
ICLR
$12.8B
$407M 0.53%
1,554,558
-434,260
-22% -$106M
GILD icon
31
Gilead Sciences
GILD
$168B
$384M 0.5%
5,500,955
+453,600
+9% +$31.9M
EXEL icon
32
Exelixis
EXEL
$12.7B
$371M 0.48%
17,547,501
-535,000
-3% -$9.93M
HLF icon
33
Herbalife
HLF
$1.23B
$371M 0.48%
8,748,564
-146,100
-2% -$7.22M
GSK icon
34
GSK
GSK
$102B
$360M 0.46%
7,531,537
+282,480
+4% +$14.2M
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$356M 0.46%
3,251,463
-986,200
-23% -$102M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$134B
$343M 0.44%
1,891,486
-385,798
-17% -$75.3M
CRWD icon
37
CrowdStrike
CRWD
$226B
$335M 0.43%
5,457,720
-143,260
-3% -$9.24M
BA icon
38
Boeing
BA
$184B
$330M 0.43%
+1,498,493
New +$334M
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.19T
$329M 0.43%
2,469,700
+1,836,000
+290% +$253M
PFE icon
40
Pfizer
PFE
$152B
$321M 0.41%
7,457,601
+5,093,860
+215% +$226M
PLTR icon
41
Palantir
PLTR
$420B
$312M 0.4%
12,959,528
+12,159,128
+1,519% +$297M
FTNT icon
42
Fortinet
FTNT
$119B
$310M 0.4%
5,299,445
-2,631,975
-33% -$152M
NGG icon
43
National Grid
NGG
$80.7B
$308M 0.4%
5,840,708
-2,036
-0% -$117K
MA icon
44
Mastercard
MA
$492B
$307M 0.4%
+882,000
New +$321M
FFIV icon
45
F5
FFIV
$23.4B
$306M 0.39%
1,537,862
-361,874
-19% -$72.4M
CBOE icon
46
Cboe Global Markets
CBOE
$29.5B
$304M 0.39%
2,454,424
-34,500
-1% -$4.21M
INCY icon
47
Incyte
INCY
$24.5B
$303M 0.39%
4,411,233
-103,900
-2% -$7.9M
NFLX icon
48
Netflix
NFLX
$311B
$296M 0.38%
4,851,000
-92,000
-2% -$5.06M
UPST icon
49
Upstart Holdings
UPST
$2.91B
$292M 0.38%
922,900
+254,900
+38% +$50.3M
DBX icon
50
Dropbox
DBX
$7.41B
$280M 0.36%
9,593,602
+1,528,369
+19% +$47.5M

Similar funds

Jim Simons's Q3 2021 Portfolio in Review

As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
  • Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
  • Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
  • Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
  • Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
  • Jim Simons opened 663 new positions and closed 653 in Q3 2021.
  • Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.